Blood and Marrow Stem Cell Transplant

About Us

Blood and Marrow Stem Cell Transplant Center aims to provide a holistic care for patients with hematologic malignancies and bone marrow disorders such as aplastic anemia and thalassemia with severe symptoms. Since technological development has increasingly emerged, medical technology along with expertise significantly improves the chance of success rates. Before starting treatment, treatment options will be thoroughly explained to the patients and family, therefore treatment plans could be mutually customized depending primarily on patient’s conditions and desires while taking both physical and mental aspects into consideration. Not only improving survival, but our comprehensive care also intends to enhance patient’s quality of life during and after treatment.

Our Superiority

  • Advanced sterilization room with positive pressure: To reduce the chance of infections during treatment, patients will be treated in isolation rooms with special air filters.
  • Well-trained and highly specialized hematologists in all types of bone marrow transplant, including autologous transplant (self-donated), allogeneic transplant using matched donor and haploidentical transplant (allogeneic transplant using half-matched donor).

Our Services

Comprehensive services at Blood and Marrow Stem Cell Transplant Center include:

  1. Hematologic malignancies
    • Leukemia
    • Lymphoma
    • Multiple myeloma
    • Myelodysplastic syndrome (MDS)
  2. Non-malignant blood disorders
    • Thalassemia
    • Aplastic anemia

Advances in technology and treatment approaches

Bone marrow and stem cell transplants are effective methods used to treat hematologic malignancies e.g. leukemia, multiple myeloma and non-Hodgkin’s lymphoma. Transplantation, considered as new hope of a cure, helps restoring the body’s ability to produce new blood cells after achieving complete remission by the administration of high-dose chemotherapy and/or radiation. Besides attaining the best possible treatment outcomes, our highly experienced hematologists have expertise in monitoring and managing graft versus host disease (GVHD) which is an immune-mediated condition resulting from a complex interaction between donor and recipient adaptive immunity. Effective management significantly reduces the chances of failure and mortality rates. As a result, the chances of being cured from blood cancers are considerably high, especially in patients who received timely treatment.

Before starting treatment

Prior to bone marrow and stem cell transplant, patients need to undergo a series of tests and procedures to assess their general health and the status of their conditions in order to ensure that they are physically prepared for the transplant. More importantly, patients need to understand their requirement for the transplant as well as all processes of treatments and expected outcomes. Possible side effects and complications caused by the transplant might arise at anytime during treatment. These often include infections due to suppressed immune function, side effects or adverse drug reactions from high-dose chemotherapy and graft versus host disease which is a possible complication of receiving a stem cell or bone marrow transplant from another person (an allogeneic transplant). Therefore, close supervision and appropriate management of these undesired effects remain extremely important.

Important Notice

A series of laboratory tests and procedures is involved during treatment in order to ensure that patients are physically eligible for receiving high-dose chemotherapy as a part of the transplant with less chances of complications. Patients’ conditions must be applicable to remain in the sterilization rooms to continue treatment for a month or even longer in some cases.